Peripheral Artery Disease: Causes, Symptoms, and Genetics

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on blood testing & biomarkers. Browse all Blood Testing & Biomarkers education

Peripheral artery disease (PAD) narrows the arteries that carry blood to the limbs, most often the legs. It affects more than 200 million people worldwide and shares deep biological roots with heart attack and stroke. Understanding its causes, warning signs, and the genetic factors that raise risk can help you recognize PAD early and have a more informed conversation with your provider.

What causes peripheral artery disease

PAD is usually driven by atherosclerosis — the gradual buildup of fatty, fibrous plaque inside artery walls. As plaque accumulates, the vessel narrows and blood flow to the legs and feet drops, especially during activity when muscles demand more oxygen. The same risk factors that damage coronary arteries drive PAD: smoking (the single strongest modifiable factor), diabetes, high blood pressure, high cholesterol, and aging. Chronic inflammation and elevated homocysteine also contribute to vessel damage.

Symptoms to watch for

The hallmark symptom is claudication — cramping or aching pain in the calves, thighs, or buttocks that appears with walking and eases with rest. Other signs include leg numbness or weakness, coldness in the lower leg or foot, slow-healing sores, changes in skin color, and weak pulses in the feet. Many people have no symptoms at all in early stages, which is why PAD is frequently underdiagnosed. Because advanced PAD raises the risk of heart attack, stroke, and, rarely, limb loss, unexplained leg symptoms warrant medical evaluation.

The genetics behind PAD risk

PAD is partly heritable, and genome-wide studies have identified variants that raise risk. The most famous is the 9p21 locus, where variants in the CDKN2B-AS1 gene (also called ANRIL) are among the most consistently replicated genetic risk factors for atherosclerosis, coronary disease, and PAD across large populations. Variants in the MTHFR gene are also relevant: MTHFR helps process homocysteine, and reduced-function variants such as C677T can raise homocysteine levels, which is associated with vascular damage. Genes influencing smoking behavior in the CHRNA3/CHRNA5 cluster on chromosome 15 add an indirect route, because they affect nicotine dependence — and smoking is PAD's leading cause. These variants shift the odds; they do not determine destiny.

How PAD is evaluated and managed

Because PAD sits inside cardiovascular medicine, evaluation and any care plan belong with a qualified clinician. Providers commonly use the ankle-brachial index — a simple blood-pressure comparison between ankle and arm — to screen for reduced flow. Broadly, the medical literature emphasizes addressing root causes: stopping smoking, controlling blood sugar and blood pressure, managing cholesterol, and supervised walking programs that improve circulation over time. These are described here as general, evidence-based context, not personal medical advice.

Where pathway-level genetics fits in

Genetics can add helpful context to your cardiovascular picture — a view of the metabolic, lipid, and inflammatory pathways that shape vascular health. The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights across systems including metabolism and inflammation. It does not diagnose PAD, measure your circulation, or predict cardiovascular events; those require clinical testing. What it provides is pathway-level insight you can bring to your provider to inform a proactive conversation. PlexusDx tells you about your biology; it does not tell you what to put in your body.

What to do with the information

If you notice leg pain when walking, coldness, or slow-healing sores, talk with a healthcare provider — early detection protects both your legs and your heart. Knowing your genetic predispositions across vascular and metabolic pathways can make that conversation more focused. Genetics is a guide, not a guarantee: your habits and clinical care carry enormous weight in PAD risk.

Frequently Asked Questions

What is the main cause of peripheral artery disease?

Atherosclerosis — plaque buildup inside artery walls — is the main cause of PAD, narrowing the vessels that supply the legs. Smoking is the single strongest modifiable risk factor, followed by diabetes, high blood pressure, high cholesterol, and aging. Chronic inflammation and elevated homocysteine also contribute to vessel damage.

Is peripheral artery disease genetic?

Partly. Genome-wide studies link PAD to variants at the 9p21 locus (CDKN2B-AS1) and to MTHFR, which affects homocysteine processing. Genes in the CHRNA3/CHRNA5 cluster influence smoking behavior, an indirect route. These variants raise risk but do not determine outcome; lifestyle and clinical care remain decisive.

Can genetic testing detect PAD?

No. Genetic testing cannot detect or diagnose peripheral artery disease. Diagnosis relies on clinical evaluation, including the ankle-brachial index and imaging performed by a provider. Genetic insight offers pathway-level context about metabolic, lipid, and inflammatory biology that complements — but never replaces — cardiovascular assessment.

Want to understand the pathways behind your cardiovascular and metabolic health? Explore the Precision Peptide Genetic Test for a pathway-level view of your biology — insight you can bring to your healthcare provider.

The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not recommend, prescribe, or determine which peptides you should use. Consult a qualified healthcare provider before beginning any peptide protocol.

This article is part of the PlexusDx Education Hub. Browse all Blood Testing & Biomarkers education